Novo Nordisk’s obesity drug Wegovy gets CDSCO approval to treat liver condition
The product is the first and only GLP-1 for adults with fatty liver disease in India, Novo Nordisk says
Read the full article1d agoen
The product is the first and only GLP-1 for adults with fatty liver disease in India, Novo Nordisk says
Read the full article
Comments
Sign in to join the conversation.
No comments yet. Be the first.